Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases-Reference-Cited by-同舟云学术

Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases

Published:2021-09-07 Issue:21 Volume:81 Page:5464-5476
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Faure Camille,Djerbi-Bouillié Rym,Domingot Anaïs,Bouzinba-Segard Haniaa,Taouji Saïd,Saidi Yanis,Bernard Sandra,Carallis Floriane,Rothe-Walther Romy^ORCID,Lenormand Jean-Luc^ORCID,Chevet Eric^ORCID,Bourdoulous Sandrine

Funder

Association pour la Recherche contre le Cancer

Fondation de France

GEFLUC Association

Société de Transfert de Technologies

Ile de France Innov

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer;Breast Cancer Research and Treatment;2024-05-15

2. Antipsychotic Zuclopenthixol Inhibits Melanoma Growth and Brain Metastasis by Inducing Apoptosis and Cell Cycle Arrest;Frontiers in Bioscience-Landmark;2024-03-29

3. Moesin affects the plasma membrane expression and the immune checkpoint function of CD47 in human ovarian clear cell carcinoma;Journal of Reproductive Immunology;2024-02

4. Radixin modulates the plasma membrane localization of CD47 in human uterine cervical adenocarcinoma cells;Journal of Reproductive Immunology;2023-08

5. Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2‐positive cancers;Molecular Oncology;2023-03-27